Large Pharma Partnerships And AI Platforms Will Open New Markets
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 8 Analysts
Published
30 Apr 25
Updated
15 Aug 25
AnalystConsensusTarget's Fair Value
€11.00
42.2% undervalued intrinsic discount15 Aug
€6.36
1Y
9.7%7D
-6.2%